STIMPOD NMS460 Nerve Stimulator— 510(k) K161091

Name: FDA 510(k) clearance K161091
Creator: U.S. Food and Drug Administration
Published: 2017-01-18

Substantially Equivalent

Xavant Technology (Pty), Ltd.

FDA 510(k) clearance K161091 for STIMPOD NMS460 Nerve Stimulator, Substantially Equivalent on 2017-01-18. Applicant: Xavant Technology (Pty), Ltd.. Device class: 2.

Clearance details

Applicant: Xavant Technology (Pty), Ltd.
Product code: Code GZJ
Device class: Class 2
Regulation: 21 CFR 882.5890
Advisory panel: Neurology
Date received: 2016-04-18
Decision date: 2017-01-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Silverton, ZA

Download summary PDF View on FDA.gov ↗

Recent devices under product code GZJ

view all

K252712 — STIMPOD NMS460 Nerve Stimulator2026-05-28
K252767 — actiTENS mini2026-01-16
K252236 — CP Relief Wand Rx - TENS/NMES2025-08-15
K232441 — Unipro (K-UNIPRO-US)2024-08-30
K241228 — TENSWave2024-08-27

More clearances from Xavant Technology (Pty), Ltd.

view all

K213049 — STIMPOD NMS450 Nerve Stimulator2022-10-16
K140853 — STIMPOD ST2-3010 NERVE STIMULATOR2014-11-06
K110118 — STIMTRODE SINGLE USE NERVE STIMULATOR2011-02-17
K102084 — STIMPOD NMS450 NERVE STIMULATOR2010-12-16
K093591 — STIMPOD MODEL NMS-400 NERVE STIMULATOR2009-12-03

Data sourced from openFDA. This site is unofficial and independent of the FDA.